Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Spitz DL"'
Autor:
Makker V; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical Center, New York, NY, USA., Perez-Fidalgo JA; INCLIVA, CIBERONC, GEICO, Hospital Clinico Universitario de Valencia, Valencia, Spain., Valabrega G; University of Turin, A.O. Ordine Mauriziano, Turin, Italy., Hamilton E; Sarah Cannon Research Institute, Nashville, TN, USA., Van Gorp T; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Sehouli J; European Competence Center for Ovarian Cancer, Charité Comprehensive Cancer Center, NOGGO, Charité-Berlin University of Medicine, Berlin, Germany., Regináčová K; Department of Oncology, University Hospital Kralovske Vinohrady, Prague, Czech Republic; Charles University, Third Faculty of Medicine, Prague, Czech Republic., Richardson DL; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Perri T; Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel., Oza AM; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada., Miller DS; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA., Alía EMG; Hospital Universitario Ramón y Cajal, Madrid, Spain., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Henry S; Belgium and Luxembourg Gynaecological Oncology Group (BGOG) and Université Catholique de Louvain CHU UCL Site Ste Elisabeth, Service d'onco-hématologie (SORMIN), Namur, Belgium., Spitz DL; Sarah Cannon Research Institute, Nashville, TN, USA; Florida Cancer Specialists & Research Institute, Wellington, FL, USA., Wimberger P; University Hospital Carl Gustav Carus, NOGGO, and Technische Universität Dresden, Dresden, Germany., Bednaříková M; University Hospital and Masaryk University, Brno, Prague, Czech Republic; Charles University, Third Faculty of Medicine, Prague, Czech Republic., Chon HS; Moffitt Cancer Center, Tampa, FL, USA., Martínez-Garcia J; Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-ARRIXACA, Murcia, Spain., Pisano C; Istituto Nazionale Tumori di Napoli, Naples, Italy., Berek JS; Stanford Women's Cancer Center, Stanford Cancer Institute, University School of Medicine, Stanford, CA, USA., Romero I; INCLIVA, CIBERONC, GEICO, Hospital Clinico Universitario de Valencia, Valencia, Spain., Scambia G; Università Cattolica del Sacro Cuore, Rome 00168, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome 00168, Italy., Fariñas-Madrid L; Vall d'Hebron Universitiy Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Buscema J; Arizona Oncology, Tucson, AZ, USA., Schochter F; University Hospital Ulm, Ulm, Germany., Li K; Karyopharm Therapeutics Inc., Newton, MA, USA., Kalyanapu P; Karyopharm Therapeutics Inc., Newton, MA, USA., Walker CJ; Karyopharm Therapeutics Inc., Newton, MA, USA., Vergote I; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. Electronic address: Ignace.vergote@uzleuven.be.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2024 Jun; Vol. 185, pp. 202-211. Date of Electronic Publication: 2024 Jun 03.
Autor:
Moore KN; Sarah Cannon Research Institute, Nashville, Tennessee. Kathleen-Moore@ouhsc.edu.; Stephenson Cancer Center at the University of Oklahoma HSC, Oklahoma City, Oklahoma., Chambers SK; The University of Arizona Cancer Center, Tucson, Arizona., Hamilton EP; Sarah Cannon Research Institute, Nashville, Tennessee.; Tennessee Oncology, PLLC, Nashville, Tennessee., Chen LM; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Oza AM; Bras Drug Development Program, Princess Margaret Cancer Centre, Toronto, Canada., Ghamande SA; Augusta University, Augusta, Georgia., Konecny GE; UCLA, Los Angeles, California., Plaxe SC; UC San Diego Health, La Jolla, California., Spitz DL; Sarah Cannon Research Institute, Nashville, Tennessee.; Florida Cancer Specialists & Research Institute, Wellington, Florida., Geenen JJJ; Netherlands Cancer Institute, Amsterdam, the Netherlands., Troso-Sandoval TA; Memorial Sloan Kettering Cancer Center, New York, New York., Cragun JM; The University of Arizona Cancer Center, Tucson, Arizona., Rodrigo Imedio E; Oncology Global Medicines Development (GMD), AstraZeneca, Cambridge, United Kingdom., Kumar S; Oncology Global Medicines Development (GMD), AstraZeneca, Cambridge, United Kingdom., Mugundu GM; Quantitative Clinical Pharmacology, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts., Lai Z; Translational Medicine, Oncology Research and Development, AstraZeneca, Boston, Massachusetts., Chmielecki J; Translational Medicine, Oncology Research and Development, AstraZeneca, Boston, Massachusetts., Jones SF; Sarah Cannon Research Institute, Nashville, Tennessee., Spigel DR; Sarah Cannon Research Institute, Nashville, Tennessee.; Tennessee Oncology, PLLC, Nashville, Tennessee., Cadoo KA; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jan 01; Vol. 28 (1), pp. 36-44. Date of Electronic Publication: 2021 Oct 13.
Autor:
Oh J; Texas Oncology, P.A., Dallas, TX, United States., Barve M; Mary Crowley Cancer Research Centers, Dallas, TX, United States; Texas Oncology, P.A., Dallas, TX, United States., Matthews CM; Texas Oncology, P.A., Dallas, TX, United States., Koon EC; Texas Oncology, P.A., Dallas, TX, United States., Heffernan TP; North Texas Gynecologic Oncology, Dallas, TX, United States., Fine B; Texas Oncology, P.A., Dallas, TX, United States., Grosen E; Cancer Care Northwest, Spokane, WA, United States., Bergman MK; Cancer Care Northwest, Spokane, WA, United States., Fleming EL; Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States., DeMars LR; Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States., West L; Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States., Spitz DL; Florida Cancer Specialists, West Palm Beach, FL, United States., Goodman H; Florida Cancer Specialists, West Palm Beach, FL, United States., Hancock KC; Texas Oncology, Fort Worth, TX, United States., Wallraven G; Gradalis, Inc., Dallas, TX, United States., Kumar P; Gradalis, Inc., Dallas, TX, United States., Bognar E; Gradalis, Inc., Dallas, TX, United States., Manning L; Gradalis, Inc., Dallas, TX, United States., Pappen BO; Gradalis, Inc., Dallas, TX, United States., Adams N; Mary Crowley Cancer Research Centers, Dallas, TX, United States., Senzer N; Mary Crowley Cancer Research Centers, Dallas, TX, United States; Gradalis, Inc., Dallas, TX, United States., Nemunaitis J; Mary Crowley Cancer Research Centers, Dallas, TX, United States; Texas Oncology, P.A., Dallas, TX, United States; Gradalis, Inc., Dallas, TX, United States; Medical City Dallas Hospital, Dallas, TX, United States. Electronic address: jnemunaitis@marycrowley.org.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2016 Dec; Vol. 143 (3), pp. 504-510. Date of Electronic Publication: 2016 Sep 24.
Autor:
Spitz DL; Department of Medicine, New York University Medical Center, New York 10016., Zucker-Franklin D, Nabi ZF
Publikováno v:
American journal of hematology [Am J Hematol] 1988 Jul; Vol. 28 (3), pp. 155-61.